Abstract
Wolman disease is the infantile form of autosomal recessive acid lipase deficiency, typically presenting in early infancy with diarrhea, massive hepatosplenomegaly, failure to thrive, and calcification of adrenal glands. Hematopoietic cell transplantation (HCT) is the only therapy reported to prevent hepatic failure and death, which without treatment occurs within the first year of life. We report a single institution's experience with HCT treatment of four Wolman patients, two of whom are long-term survivors (the longest survival reported to date, (4 and 11 years). Survivors showed resolution of diarrhea within weeks after engraftment, normalized hepatic function, improved hepatosplenomegaly, and in one patient normal adrenal function. The older patient has normal adaptive functions but mild to moderate neurocognitive deficiencies thought to be secondary to treatment and other medical problems. The younger patient has age-appropriate neurodevelopmental and adaptive abilities. We conclude that Wolman disease can be successfully treated with HCT, and that hepatic and cognitive function can be preserved with early diagnosis and timely referral to a transplant center.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abramov A, Schorr S, Wolman M . Generalized xanthomatosis with calcified adrenals. AMA J Dis Child 1956; 91: 282–286.
Wolman M, Sterk VV, Gatt S, Frenkel M . Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics 1961; 28: 742–757.
Sando GN, Rosenbaum LM . Human lysosomal acid lipase/cholesteryl ester hydrolase. Purification and properties of the form secreted by fibroblasts in microcarrier culture. J Biol Chem 1985; 260: 15186–15193.
Patrick AD, Lake BD . Deficiency of an acid lipase in Wolman's disease. Nature 1969; 222: 1067–1068.
Fitoussi G, Negre-Salvayre A, Pieraggi MT, Salvayre R . New pathogenetic hypothesis for Wolman disease: possible role of oxidized low-density lipoproteins in adrenal necrosis and calcification. Biochem J 1994; 301 (Part 1): 267–273.
Krivit W, Freese D, Chan KW, Kulkarni R . Wolman's disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant 1992; 10 (Suppl 1): 97–101.
Krivit W, Peters C, Dusenbery K, Ben-Yoseph Y, Ramsey NK, Wagner JE et al. Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant 2000; 26: 567–570.
Stein J, Garty BZ, Dror Y, Fenig E, Zeigler M, Yaniv I . Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation. Eur J Pediatr 2007; 166: 663–666.
Kyriakides EC, Paul B, Balint JA . Lipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman's disease, and their apparent correction in vitro. J Lab Clin Med 1972; 80: 810–816.
Brown MS, Sobhani MK, Brunschede GY, Goldstein JL . Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. J Biol Chem 1976; 251: 3277–3286.
Kahana D, Berant M, Wolman M . Primary familial xanthomatosis with adrenal involvement (Wolman's disease). Report of a further case with nervous system involvement and pathogenetic considerations. Pediatrics 1968; 42: 70–76.
Roytta M, Fagerlund AS, Toikkanen S, Salmi TT, Jorde LB, Forsius HR et al. Wolman disease: morphological, clinical and genetic studies on the first Scandinavian cases. Clin Genet 1992; 42: 1–7.
Hoeg JM, Demosky Jr SJ, Pescovitz OH, Brewer Jr HB . Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet 1984; 36: 1190–1203.
Dorin RI, Qualls CR, Crapo LM . Diagnosis of adrenal insufficiency. Ann Intern Med 2003; 139: 194–204.
Abdu TA, Elhadd TA, Neary R, Clayton RN . Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo–pituitary–adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84: 838–843.
Rose SR, Lustig RH, Burstein S, Pitukcheewanont P, Broome DC, Burghen GA . Diagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res 1999; 52: 73–79.
Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W . Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998; 83: 1558–1562.
Aubourg P . The expanding world of primary adrenal insufficiencies. Eur J Endocrinol 1997; 137: 10–12.
Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM . Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004; 33: 1049–1056.
Shalet SM, Brennan BM . Growth and growth hormone status after a bone marrow transplant. Horm Res 2002; 58 (Suppl 1): 86–90.
Guazzi GC, Martin JJ, Philippart M, Roels H, Hooft C, Van der Eecken H et al. Wolman's disease. Distribution and significance of the central nervous system lesions. Pathol Eur 1968; 3: 266–277.
Wolman M . Involvement of nervous tissue in primary familial xanthomatosis with adrenal calcification. Pathol Eur 1968; 3: 259–265.
Kamoshita S, Landing BH . Distribution of lesions in myenteric plexus and gastrointestinal mucosa in lipidoses and other neurologic disorders of children. Am J Clin Pathol 1968; 49: 312–318.
Lowden JA, Barson AJ, Wentworth P . Wolman's disease: a microscopic and biochemical study showing accumulation of ceroid and esterified cholesterol. Can Med Assoc J 1970; 102: 402–405.
Crocker AC, Vawter GF, Neuhauser EB, Rosowsky A . Wolman's disease: three new patients with a recently described lipidosis. Pediatrics 1965; 35: 627–640.
Acknowledgements
We thank Eileen Hanson for her dedication and persistence in obtaining the necessary data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tolar, J., Petryk, A., Khan, K. et al. Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant 43, 21–27 (2009). https://doi.org/10.1038/bmt.2008.273
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.273
Keywords
This article is cited by
-
Dietary Management of Metabolic Liver Disease
Current Hepatology Reports (2023)
-
Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party
Bone Marrow Transplantation (2023)
-
“Why them, why me, why us?” The experiences of parents of children with lysosomal acid lipase deficiency: an interpretative phenomenological analysis study
Orphanet Journal of Rare Diseases (2022)
-
Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up
Orphanet Journal of Rare Diseases (2021)
-
Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease
Orphanet Journal of Rare Diseases (2021)